Join Wendy Blackburn, Intouch Group's EVP of marketing and communications, for a FREE virtual conference hosted by DTC Perspectives on all things COVID -- May 19, 2020.
Intouch is partnering with Heart to Heart International to help stop the spread of the coronavirus through a monetary donation and more.
The COVID-19 pandemic has created new opportunities for pharmaceutical manufacturers to enhance their existing payer relationships while also delivering for HCPs and patients faced with navigating their new access and reimbursement realities.
The degree to which healthcare providers are affected by the COVID-19 pandemic depends on a number of factors. It’s important for pharma marketers to understand their mindset in these uncertain times.
New guidance from the FDA and EMA has opened the door to clinical trial protocol flexibility in order to maintain the integrity of the research currently underway. This Intouch POV looks at the challenges & opportunities for pharma marketers.
COVID-19 has upended our healthcare system and thrust pharmaceutical product patient support programs onto the front lines of treatment management. Pharmaceutical companies have the opportunity to demonstrate their commitment to patients and HCPs by ensuring that clear and relevant information is easily available.
During the coronavirus pandemic, one vitally important topic not receiving much public and media attention is how to keep the “at-risk” patient population on therapy. Intouch B2D has a plan.
While pharmaceutical companies have long been the target of public mistrust and negative media attention, right now the industry is doing more than its fair share of rolling up its sleeves to help.
The COVID-19 pandemic is a powerful trigger that will change human behaviors and accelerate adoption of new methods of scientific information-sharing among medical professionals, powered by technology and virtual forms of collaboration. This POV looks at the challenges and opportunities when navigating this new world.
Intouch is committed to sharing information about how the pharma marketing industry is adapting to challenges presented by COVID-19, as well as how Intouch Group and its affiliates can help clients work within the evolving parameters we face. In that spirit, our sister affiliate, Intouch B2D, recently asked clients large